{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:40Z","timestamp":1787003860690,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07731","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T05:19:06Z","timestamp":1421385546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dual ameliorative effects of Ningdong granule on dopamine in rat models of Tourette's syndrome"],"prefix":"10.1038","volume":"5","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,16]]},"reference":[{"key":"BFsrep07731_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jpsychores.2009.09.002","volume":"67","author":"MH Bloch","year":"2009","unstructured":"Bloch, M. H. & Leckman, J. F. Clinical course of Tourette's syndrome. J. Psychosom. Res. 67, 497\u2013501 (2009).","journal-title":"J. Psychosom. Res."},{"key":"BFsrep07731_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1176\/jnp.15.1.116","volume":"15","author":"ML Berthier","year":"2003","unstructured":"Berthier, M. L., Campos, V. M., Kulisevsky, J. & Valero, J. A. Heroin and malignant coprolalia in Tourette's syndrome. J. Neuropsych. Clin. Neurosci. 15, 116\u2013117 (2003).","journal-title":"J. Neuropsych. Clin. Neurosci."},{"key":"BFsrep07731_CR3","first-page":"578","volume":"119","author":"JN Seignot","year":"1961","unstructured":"Seignot, J. N. Un cas de maladie des tics de Gilles de la Tourette gu\u00e9ri par le R.1625. Ann. M\u00e9d-Psychol. 119, 578\u2013579 (1961).","journal-title":"Ann. M\u00e9d-Psychol."},{"key":"BFsrep07731_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neubiorev.2012.10.014","volume":"37","author":"A Hartmann","year":"2013","unstructured":"Hartmann, A. & Worbe, Y. Pharmacological treatment of Gilles de la Tourette syndrome. Neurosci. Biobehav. Rev. 37, 1157\u20131161 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFsrep07731_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","volume":"273","author":"SS Wolf","year":"1996","unstructured":"Wolf, S. S. et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273, 1225\u20131227 (1996).","journal-title":"Science"},{"key":"BFsrep07731_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2003.12.006","volume":"219","author":"K Minzer","year":"2004","unstructured":"Minzer, K., Lee, O., Hong, J. J. & Singer, H. S. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum. J. Neurol. Sci. 219, 55\u201361 (2004).","journal-title":"J. Neurol. Sci."},{"key":"BFsrep07731_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","volume":"33","author":"DF Wong","year":"2008","unstructured":"Wong, D. F. et al. Mechanisms of dopaminergic and serotonergic neurotrans-mission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacol 33, 1239\u20131251 (2008).","journal-title":"Neuropsychopharmacol"},{"key":"BFsrep07731_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ana.21809","volume":"67","author":"TD Steeves","year":"2010","unstructured":"Steeves, T. D. et al. Extrastriatal dopaminergic dysfunction in Tourette syndrome. Ann. Neurol. 67, 170\u2013181 (2010).","journal-title":"Ann. Neurol."},{"key":"BFsrep07731_CR9","first-page":"79","volume":"16","author":"HS Singer","year":"1981","unstructured":"Singer, H. S., Rabins, P. & Coyle, J. T. Serum haloperidol levels in Gilles di la Tourette's syndrome. Biol. Psychiat. 16, 79\u201384 (1981).","journal-title":"Biol. Psychiat."},{"key":"BFsrep07731_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/jnnp.57.6.688","volume":"57","author":"N Turjanski","year":"1994","unstructured":"Turjanski, N. et al. Pet Studies of the Presynaptic and Postsynaptic Dopaminergic System in Tourette's Syndrome. J. Neurol. Neurosur. Ps. 57, 688\u2013692 (1994).","journal-title":"J. Neurol. Neurosur. Ps."},{"key":"BFsrep07731_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0924-977X(00)00134-6","volume":"11","author":"M Stamenkovic","year":"2001","unstructured":"Stamenkovic, M. et al. No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study. Eur Neuropsychopharmcol. 11, 69\u201374 (2001).","journal-title":"Eur Neuropsychopharmcol."},{"key":"BFsrep07731_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10072-005-0448-z","volume":"26","author":"C Cianchetti","year":"1997","unstructured":"Cianchetti, C., Fratta, A., Pisano, T. & Minafra, L. Pergolide improvement in neuroleptic resistant Tourette cases: various mechanisms causing tics. Neurol. Sci. 26, 137\u2013139 (1997).","journal-title":"Neurol. Sci."},{"key":"BFsrep07731_CR13","doi-asserted-by":"publisher","first-page":"A121","DOI":"10.1212\/WNL.56.1.121","volume":"56","author":"MH Anca","year":"2001","unstructured":"Anca, M. H., Giladi, N. & Korczyn, A. D. Ropinirole for Tourette syndrome. Neurology 56, A121 (2001).","journal-title":"Neurology"},{"key":"BFsrep07731_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.neubiorev.2012.09.010","volume":"37","author":"M Bronfeld","year":"2013","unstructured":"Bronfeld, M., Israelashvili, M. & Bar-Gad, I. Pharmacological animal models of Tourette syndrome. Neurosci. Biobehav. Rev. 37, 1101\u20131119 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFsrep07731_CR15","first-page":"221","volume":"35","author":"BI Diamond","year":"1982","unstructured":"Diamond, B. I., Reyes, M. G. & Borison, R. A new animal model for Tourette syndrome. Adv. Neurol. 35, 221\u2013225 (1982).","journal-title":"Adv. Neurol."},{"key":"BFsrep07731_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jep.2009.05.015","volume":"124","author":"H Lv","year":"2009","unstructured":"Lv, H., Li, A., Ma, H., Liu, F. & Xu, H. Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models. J. Ethnapharmacol. 124, 488\u2013492 (2009).","journal-title":"J. Ethnapharmacol."},{"key":"BFsrep07731_CR17","doi-asserted-by":"crossref","unstructured":"Wang, D., Li, W., Liu, X. et al. Chinese medicine formula ''Jian-Pi-Zhi-DongDecoction'' attenuates Tourette syndrome via downregulating the expression of dopamine transporter in mice. Evid. Based Complement Altern. Med. (2013).","DOI":"10.1155\/2013\/385685"},{"key":"BFsrep07731_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0006-8993(93)90369-X","volume":"604","author":"H Hirata","year":"1993","unstructured":"Hirata, H., Ogawa, N., Asanuma, M. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. Brain Res. 604, 197\u2013204 (1993).","journal-title":"Brain Res."},{"key":"BFsrep07731_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1023\/A:1007553323461","volume":"25","author":"N Wakata","year":"1999","unstructured":"Wakata, N., Araki, Y., Sugimoto, H., Iguchi, H. & Kinoshita, M. IDPN-induced monoamine and hydroxyl radical changes in the rat brain. Neurochem. Res. 25, 401\u2013404 (1999).","journal-title":"Neurochem. Res."},{"key":"BFsrep07731_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0167-0115(94)00105-7","volume":"55","author":"Y Kawada","year":"1995","unstructured":"Kawada, Y., Ogawa, N., Asanuma, M. & Mori, A. Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model. Regulatory Peptides 55, 103\u2013110 (1995).","journal-title":"Regulatory Peptides"},{"key":"BFsrep07731_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","volume":"46","author":"E Shapiro","year":"1998","unstructured":"Shapiro, E. et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch. Gen. Psychiat. 46, 722\u2013730 (1998).","journal-title":"Arch. Gen. Psychiat."},{"key":"BFsrep07731_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","volume":"154","author":"FR Sallee","year":"1997","unstructured":"Sallee, F. R., Nesbitt, L., Jackson, C., Sine, L. & Sethuraman, G. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am. J. Psychiat. 154, 1057\u20131062 (1997).","journal-title":"Am. J. Psychiat."},{"key":"BFsrep07731_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/1098-2396(20000901)37:3<194::AID-SYN3>3.0.CO;2-A","volume":"37","author":"KC Berridge","year":"2000","unstructured":"Berridge, K. C. & Aldridge, J. Super-stereotypy I: Enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse 37, 194\u2013204 (2000).","journal-title":"Synapse"},{"key":"BFsrep07731_CR24","first-page":"50","volume":"13","author":"E Chan","year":"2010","unstructured":"Chan, E., Tan, M., Xin, J., Sudarsanam, S. & Johnson, D. E. Interactions between traditional Chinese medicines and Western therapeutics. Curr. Opin. Drug Discov. Devel. 13, 50\u201365 (2010).","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"BFsrep07731_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11655-009-0261-2","volume":"15","author":"AY Li","year":"2009","unstructured":"Li, A. Y., Cong, S., Lu, H., Li, J. J. & Zhao, L. Clinical observation on treatment of Tourette syndrome by integrative medicine. Chin. J. Integr. Med. 15, 261\u2013265 (2009).","journal-title":"Chin. J. Integr. Med."},{"key":"BFsrep07731_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/147323001003800119","volume":"38","author":"L Zhao","year":"2010","unstructured":"Zhao, L., Li, A. Y., Lv, H., Liu, F. Y. & Qi, F. H. Traditional Chinese medicine Ningdong gradule: the beneficial effects in Tourette's syndrome disorder. J. Int. Med. Res. 38, 169\u2013175 (2010).","journal-title":"J. Int. Med. Res."},{"key":"BFsrep07731_CR27","first-page":"33","volume":"32","author":"AY Li","year":"2008","unstructured":"Li, A. Y. et al. Clinic research of Ningdong granule in treating Tourette syndrome. J. Shan. Uni. Trad. Chin. Med. 32, 33\u201335 (2008) (in Chinese).","journal-title":"J. Shan. Uni. Trad. Chin. Med."},{"key":"BFsrep07731_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/syn.20460","volume":"62","author":"TC Napier","year":"2008","unstructured":"Napier, T. C. & Istre, E. D. Methamphetamine-induced sensitization includes a functional up-regulation of ventral pallidal 5-HT2A\/2C receptors. Synapse 62, 14\u201321 (2008).","journal-title":"Synapse"},{"key":"BFsrep07731_CR29","first-page":"467","volume":"3","author":"LL Wei","year":"2011","unstructured":"Wei, L. L. et al. HPLC-ECD determination of on striatal extracellular levels of monoamine neurotransmitter. Chin. J. Pharmacol. Anal. 3, 467\u2013470 (2011).","journal-title":"Chin. J. Pharmacol. Anal."},{"key":"BFsrep07731_CR30","first-page":"15","volume":"50","author":"JJ Li","year":"2009","unstructured":"Li, J. J. An-yuan Li's experience of treatment for Tourette's disorder. J. Trad. Chin. Med. 50, 15\u201316 (2009) (in Chinese).","journal-title":"J. Trad. Chin. Med."},{"key":"BFsrep07731_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0773.1963.tb01731.x","volume":"20","author":"A Randrup","year":"1963","unstructured":"Randrup, A., Munkvad, I. & Udsen, P. Adrenergic mechanisms and amphetamine induced abnormal behaviour. Acta. Pharmacol. Toxicol. 20, 145\u2013157 (1963).","journal-title":"Acta. Pharmacol. Toxicol."},{"key":"BFsrep07731_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1365-2125.1990.tb03848.x","volume":"30","author":"O Blin","year":"1990","unstructured":"Blin, O., Masson, G., Azulay, J. P., Fondarai, J. & Serratrice, G. Apomorphine-induced blinking and yawning in healthy volunteers. Brit. J. Clin. Pharmaco. 30, 769\u2013773 (1990).","journal-title":"Brit. J. Clin. Pharmaco."},{"key":"BFsrep07731_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0149-7634(89)80050-8","volume":"13","author":"JL Cadet","year":"1989","unstructured":"Cadet, J. L. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome: Behavioral and biochemical pharmacology. Neurosci. Biobehav. Rev. 13, 39\u201345 (1989).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFsrep07731_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/FBP.0b013e32832ec5ea","volume":"20","author":"S Al Kadasah","year":"2009","unstructured":"Al Kadasah, S. et al. Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats. Behav. Pharmacol. 20, 356\u2013360 (2009).","journal-title":"Behav. Pharmacol."},{"key":"BFsrep07731_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/brain\/111.5.1211","volume":"111","author":"AR Crossman","year":"1988","unstructured":"Crossman, A. R., Mitchell, I. J., Sambrook, M. A. & Jackson, A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea. Brain 111, 1211\u20131233 (1988).","journal-title":"Brain"},{"key":"BFsrep07731_CR36","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/brain\/awp142","volume":"132","author":"KW McCairn","year":"2009","unstructured":"McCairn, K. W., Bronfeld, M., Belelovsky, K. & Bar-Gad, I. The neurophysiological correlates of motor tics following focal striatal disinhibition. Brain 132, 2125\u20132138 (2009).","journal-title":"Brain"},{"key":"BFsrep07731_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0022-510X(81)90109-X","volume":"51","author":"A Barbeau","year":"1981","unstructured":"Barbeau, A. et al. Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. J. Neurol. Sci. 51, 311\u2013327 (1981).","journal-title":"J. Neurol. Sci."},{"key":"BFsrep07731_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.2042-7158.1967.tb09604.x","volume":"19","author":"NE Anden","year":"1967","unstructured":"Anden, N. E. et al. Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627\u2013628 (1967).","journal-title":"J. Pharm. Pharmacol."},{"key":"BFsrep07731_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00019052-199808000-00014","volume":"11","author":"MM Robertson","year":"1998","unstructured":"Robertson, M. M. & Stern, J. S. Tic disorders: new developments in Tourette syndrome and related disorders. Curr. Opin. Neurol. 11, 373\u2013380 (1998).","journal-title":"Curr. Opin. Neurol."},{"key":"BFsrep07731_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0079-6123(08)00924-2","volume":"172","author":"TD Steeves","year":"2008","unstructured":"Steeves, T. D. & Fox, S. H. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog. Brain Res. 172, 495\u2013507 (2008).","journal-title":"Prog. Brain Res."},{"key":"BFsrep07731_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1748-1716.1971.tb05213.x","volume":"37","author":"LO Farnebo","year":"1971","unstructured":"Farnebo, L. O., & Hamberger, B. Drug induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta. Physiol. Scand. 37 (suppl), 35\u201341 (1971).","journal-title":"Acta. Physiol. Scand."},{"key":"BFsrep07731_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/jnp.2009.21.1.13","volume":"21","author":"AE Cavanna","year":"2009","unstructured":"Cavanna, A. E., Servo, S., Monaco, F. & Roberson, M. M. The behavioral spectrum of Gilles de la Tourette syndrome. J. Neuropsychiat. Clin. Neurosci. 21, 13\u201323 (2009).","journal-title":"J. Neuropsychiat. Clin. Neurosci."},{"key":"BFsrep07731_CR43","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","volume":"360","author":"JF Leckman","year":"2002","unstructured":"Leckman, J. F. Tourette's syndrome. Lancet 360, 1577\u20131586 (2002).","journal-title":"Lancet"},{"key":"BFsrep07731_CR44","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","volume":"56","author":"KD Gadow","year":"1999","unstructured":"Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E. & Grossman, S. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch. Gen. Psychiat. 56, 330\u2013336 (1999).","journal-title":"Arch. Gen. Psychiat."},{"key":"BFsrep07731_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00004714-199310000-00008","volume":"13","author":"CH McDougle","year":"1993","unstructured":"McDougle, C. H. et al. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J. Clin. Psychopharm. 13, 354\u2013358 (1993).","journal-title":"J. Clin. Psychopharm."},{"key":"BFsrep07731_CR46","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/sj.npp.1300469","volume":"29","author":"F Levy","year":"2004","unstructured":"Levy, F. Synaptic gating and ADHD: a biological theory of comorbidity of ADHD and anxiety. Neuropsychopharmcol. 29, 1589\u20131596 (2004).","journal-title":"Neuropsychopharmcol."},{"key":"BFsrep07731_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2007.03.002","volume":"30","author":"SD Iversen","year":"2007","unstructured":"Iversen, S. D. & Iversen, L. L. Dopamine: 50 years in perspective. Trends Neurosci. 30, 188\u2013193 (2007).","journal-title":"Trends Neurosci."},{"key":"BFsrep07731_CR48","first-page":"65","volume":"47","author":"HX Tang","year":"2013","unstructured":"Tang, H. X. & Li, A. Y. Treatment of 30 cases of Tourette's syndrome with attention deficit hyperactivity disorder by \u201cNingdong Granule\u201d. Sh. J. TCM. 47, 65\u201366 (2013) (in Chinese).","journal-title":"Sh. J. TCM."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07731","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T16:26:26Z","timestamp":1672935986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep07731"],"URL":"https:\/\/doi.org\/10.1038\/srep07731","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,16]]},"assertion":[{"value":"12 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7731"}}